DermTech (DMTK) Tops Q4 EPS by 1c

DermTech (NASDAQ: DMTK) reported Q4 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $4.04 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Yum! Brands (YUM) PT Lowered to $180 at Argus